{"news_desk": "Business", "print_page": "2", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "", "original": "By THE ASSOCIATED PRESS", "person": [], "organization": "THE ASSOCIATED PRESS"}, "abstract": "Study conducted by Eli Lilly and Boehringer Ingelheim, manufacturers of  drug Jardiance, finds drug reduces risk of heart attacks and strokes that are number one killer of diabetes patients.", "type_of_material": "Brief", "word_count": "105", "lead_paragraph": "New data shows Jardiance cuts the risk of heart attack and strokes that are the top killers of diabetes patients.", "pub_date": "2015-08-21T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Study Finds Drug Lowers Risk of Diabetes Complications ", "content_kicker": "Business Briefing", "print_headline": "Study Finds Drug Lowers Risk of Diabetes Complications "}, "snippet": "New data shows Jardiance cuts the risk of heart attack and strokes that are the top killers of diabetes patients.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/08/21/business/study-finds-drug-lowers-risk-of-diabetes-complications.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Diabetes", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Eli Lilly and Company", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Boehringer Ingelheim GmbH", "name": "organizations"}, {"rank": "5", "is_major": "Y", "value": "Heart", "name": "subject"}, {"rank": "6", "is_major": "Y", "value": "Stroke", "name": "subject"}], "blog": [], "_id": "55d674a938f0d81d6b2efeed", "source": "The New York Times"}